Endocrine function in obesity;Funcion endocrina en la obesidad

Endocrinologia y Nutricion

Volumn 58, Issue 8, 2011, Pages 422-432

  Álvarez Castro, Paula ^a   Sangiao Alvarellos, Susana ^a,b   Brandón Sandá, Iria ^b   Cordido, Fernando ^b  

^a Hospital Lucus Augusti   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

Endocrinology; Hormonas; Hormones; Obesidad; Obesity

Indexed keywords

GHRELIN; GONADOTROPIN; LEPTIN; LIOTHYRONINE; SOMATOSTATIN; TESTOSTERONE; THYROTROPIN; ADIPONECTIN; HUMAN GROWTH HORMONE; HYDROCORTISONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; THYROID HORMONE;

ABDOMINAL OBESITY; ADIPOCYTE; ADIPOSE TISSUE; ENDOCRINE FUNCTION; GONADOTROPIN BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE RELEASE; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; LIOTHYRONINE BLOOD LEVEL; MORBID OBESITY; OBESITY; SHORT SURVEY; TESTOSTERONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; BLOOD; ENDOCRINE SYSTEM; FEMALE; HYPERINSULINISM; MALE; METABOLISM; PATHOPHYSIOLOGY; REVIEW; SECRETION;

ADIPONECTIN; ADIPOSE TISSUE; ENDOCRINE SYSTEM; FEMALE; GHRELIN; GONADAL STEROID HORMONES; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPERINSULINISM; LEPTIN; MALE; OBESITY; SEX HORMONE-BINDING GLOBULIN; SOMATOSTATIN; THYROID HORMONES;

EID: 80053601723     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2011.05.015     Document Type: Short Survey

References (71)

1. Bessesen D.H. Update on obesity. J Clin Endocrinol Metab 2008, 93:2027-2034.
2. Flegal K.M., Carroll M.D., Ogden C.L., Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002, 288:1723-1727.
3. Flegal K.M., Carroll M.D., Kuczmarski R.J., Johnson C.L. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998, 22:39-47.
4. Salcedo V., Gutierrez-Fisac J.L., Guallar-Castillon P., Rodriguez-Artalejo F. Trends in overweight and misperceived overweight in Spain from 1987 to 2007. Int J Obes (Lond) 2010, 34:1759-1765.
5. Hernandez-Mijares A., Sola-Izquierdo E., Ballester-Mecho F., Mari-Herrero M.T., Gilabert-Moles J.V., Gimeno-Clemente N., et al. Obesity and overweight prevalences in rural and urban populations in East Spain and its association with undiagnosed hypertension and Diabetes Mellitus: a cross-sectional population-based survey. BMC Res Notes 2009, 2:151.
6. Polonsky K.S., Sturis J., Bell G.I. Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 1996, 334:777-783.
7. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846.
8. Montague C.T., O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 2000, 49:883-888.
9. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
10. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89:2548-2556.
11. Peino R., Fernandez Alvarez J., Penalva A., Considine R.V., Rodriguez-Segade S., Rodriguez-Garcia J., et al. Acute changes in free-fatty acids (FFA) do not alter serum leptin levels. J Endocrinol Invest 1998, 21:526-530.
12. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., et al. Identification and expression cloning of a leptin receptor. OB-R Cell 1995, 83:1263-1271.
13. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010, 316:129-139.
14. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
15. Rajala M.W., Qi Y., Patel H.R., Takahashi N., Banerjee R., Pajvani U.B., et al. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 2004, 53:1671-1679.
16. Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436:356-362.
17. Ost A., Danielsson A., Liden M., Eriksson U., Nystrom F.H., Stralfors P. Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes. FASEB J 2007, 21:3696-3704.
18. van der Lely A.J., Tschop M., Heiman M.L., Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004, 25:426-457.
19. Alvarez P., Isidro L., Peino R., Leal-Cerro A., Casanueva F.F., Dieguez C., et al. Effect of acute reduction of free fatty acids by acipimox on growth hormone-releasing hormone-induced GH secretion in type 1 diabetic patients. Clin Endocrinol (Oxf) 2003, 59:431-436.
20. Cordido F., Penalva A., Dieguez C., Casanueva F.F. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab 1993, 76:819-823.
21. Cordido F., Casanueva F.F., Dieguez C. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity. J Clin Endocrinol Metab 1989, 68:290-293.
22. Clasey J.L., Weltman A., Patrie J., Weltman J.Y., Pezzoli S., Bouchard C., et al. Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. J Clin Endocrinol Metab 2001, 86:3845-3852.
23. Cordido F., Garcia-Buela J., Sangiao-Alvarellos S., Martinez T., Vidal O. The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors. Mediators Inflamm 2010, 2010:4345-4362.
24. Ozata M., Dieguez C., Casanueva F.F. The inhibition of growth hormone secretion presented in obesity is not mediated by the high leptin levels: a study in human leptin deficiency patients. J Clin Endocrinol Metab 2003, 88:312-316.
25. Cordido F., Fernandez T., Martinez T., Penalva A., Peino R., Casanueva F.F., et al. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism. J Clin Endocrinol Metab 1998, 83:4350-4354.
26. Alvarez P., Isidro L., Leal-Cerro A., Casanueva F.F., Dieguez C., Cordido F. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity. Clin Endocrinol (Oxf) 2002, 56:487-492.
27. Haqq A.M., Farooqi I.S., O'Rahilly S., Stadler D.D., Rosenfeld R.G., Pratt K.L., et al. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab 2003, 88:174-178.
28. Kojima M., Hosoda H., Matsuo H., Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2001, 12:118-122.
29. Alvarez-Castro P., Isidro M.L., Garcia-Buela J., Leal-Cerro A., Broglio F., Tassone F., et al. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients. Clin Endocrinol (Oxf) 2004, 61:250-255.
30. Cordido F., Alvarez-Castro P., Isidro M.L., Casanueva F.F., Dieguez C. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. Eur J Endocrinol 2003, 149:117-122.
31. Rachon D., Teede H. Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options. Mol Cell Endocrinol 2010, 316:172-179.
32. Leenen R., van der Kooy K., Seidell J.C., Deurenberg P., Koppeschaar H.P. Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocrinol Metab 1994, 78:1515-1520.
33. Kaufman J.M., Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005, 26:833-876.
34. Mah P.M., Wittert G.A. Obesity and testicular function. Mol Cell Endocrinol 2010, 316:180-186.
35. Derby C.A., Zilber S., Brambilla D., Morales K.H., McKinlay J.B. Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 2006, 65:125-131.
36. Isidro M.L., Alvarez P., Martinez T., Cordido F. [Neuroendocrine disturbances in obesity]. Rev Med Univ Navarra 2004, 48:24-29.
37. Isidori A.M., Caprio M., Strollo F., Moretti C., Frajese G., Isidori A., et al. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 1999, 84:3673-3680.
38. Maggio M., Lauretani F., Ceda G.P., Bandinelli S., Basaria S., Paolisso G., et al. Estradiol and metabolic syndrome in older italian men: The InCHIANTI Study. J Androl 2010, 31:155-162.
39. Hall S.A., Esche G.R., Araujo A.B., Travison T.G., Clark R.V., Williams R.E., et al. Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample. J Clin Endocrinol Metab 2008, 93:3870-3877.
40. Pasquali R., Cantobelli S., Casimirri F., Capelli M., Bortoluzzi L., Flamia R., et al. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 1993, 77:341-346.
41. Pasquali R., Gagliardi L., Vicennati V., Gambineri A., Colitta D., Ceroni L., et al. ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution and parameters of the metabolic syndrome. Int J Obes Relat Metab Disord 1999, 23:419-424.
42. Stewart P.M., Boulton A., Kumar S., Clark P.M., Shackleton C.H. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 1999, 84:1022-1027.
43. Purnell J.Q., Kahn S.E., Samuels M.H., Brandon D., Loriaux D.L., Brunzell J.D. Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss. Am J Physiol Endocrinol Metab 2009, 296:E351-E357.
44. Roelfsema F., Kok P., Pereira A.M., Pijl H. Cortisol production rate is similarly elevated in obese women with or without the polycystic ovary syndrome. J Clin Endocrinol Metab 2010, 95:3318-3324.
45. Morton N.M. Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease. Mol Cell Endocrinol 2010, 316:154-164.
46. Paulsen S.K., Pedersen S.B., Fisker S., Richelsen B. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity (Silver Spring) 2007, 15:1954-1960.
47. Fernández-Vázquez G., Torrecilla García M.A., Rubio Herrera M.A. El síndrome metabólico como síndrome de Cushing intrahepatocitario. Endocrinol Nutr 2011, 58:153-156.
48. Tschop M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50:707-709.
49. Otto B., Cuntz U., Fruehauf E., Wawarta R., Folwaczny C., Riepl R.L., et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001, 145:669-673.
50. Ukkola O. Ghrelin and insulin metabolism. Eur J Clin Invest 2003, 33:183-185.
51. Shuto Y., Shibasaki T., Otagiri A., Kuriyama H., Ohata H., Tamura H., et al. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 2002, 109:1429-1436.
52. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50:1714-1719.
53. Cummings D.E., Frayo R.S., Marmonier C., Aubert R., Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol Endocrinol Metab 2004, 287:E297-E304.
54. Hansen T.K., Dall R., Hosoda H., Kojima M., Kangawa K., Christiansen J.S., et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 2002, 56:203-206.
55. Diz-Lois M.T., Garcia-Buela J., Suarez F., Sangiao-Alvarellos S., Vidal O., Cordido F. Fasting and postprandial plasma ghrelin levels are decreased in patients with liver failure previous to liver transplantation. Endocrine 2009, 35:467-476.
56. Diz-Lois M.T., Garcia-Buela J., Suarez F., Sangiao-Alvarellos S., Vidal O., Cordido F. Altered fasting and postprandial plasma ghrelin levels in patients with liver failure are normalized after liver transplantation. Eur J Endocrinol 2010, 163:609-616.
57. Sangiao-Alvarellos S., Helmling S., Vazquez M.J., Klussmann S., Cordido F. Ghrelin neutralization during fasting-refeeding cycle impairs the recuperation of body weight and alters hepatic energy metabolism. Mol Cell Endocrinol 2011, 335:177-188.
58. English P.J., Ghatei M.A., Malik I.A., Bloom S.R., Wilding J.P. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 2002, 87:2984.
59. Cummings D.E., Clement K., Purnell J.Q., Vaisse C., Foster K.E., Frayo R.S., et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 2002, 8:643-644.
60. Gimenez-Palop O., Gimenez-Perez G., Mauricio D., Gonzalez-Clemente J.M., Potau N., Berlanga E., et al. A lesser postprandial suppression of plasma ghrelin in Prader-Willi syndrome is associated with low fasting and a blunted postprandial PYY response. Clin Endocrinol (Oxf) 2007, 66:198-204.
61. Perez-Fontan M., Cordido F., Rodriguez-Carmona A., Peteiro J., Garcia-Naveiro R., Garcia-Buela J. Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis. Nephrol Dial Transplant 2004, 19:2095-2100.
62. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002, 346:1623-1630.
63. Adrian T.E., Ferri G.L., Bacarese-Hamilton A.J., Fuessl H.S., Polak J.M., Bloom S.R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985, 89:1070-1077.
64. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002, 418:650-654.
65. Karra E., Batterham R.L. The role of gut hormones in the regulation of body weight and energy homeostasis. Mol Cell Endocrinol 2010, 316:120-128.
66. Fehse F., Trautmann M., Holst J.J., Halseth A.E., Nanayakkara N., Nielsen L.L., et al. Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab 2005, 90:5991-5997.
67. Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol 2010, 316:165-171.
68. Marzullo P., Minocci A., Tagliaferri M.A., Guzzaloni G., Di Blasio A., De Medici C., et al. Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants. J Clin Endocrinol Metab 2010, 95:3965-3972.
69. Mantzoros C.S., Ozata M., Negrao A.B., Suchard M.A., Ziotopoulou M., Caglayan S., et al. Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans. J Clin Endocrinol Metab 2001, 86:3284-3291.
70. Reinehr T., de Sousa G., Andler W. Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab 2006, 91:3088-3091.
71. Biondi B. Thyroid and obesity: an intriguing relationship. J Clin Endocrinol Metab 2010, 95:3614-3617.